AG007ZTF

137132-70-8 | Naphtho[2,3-f]quinoxaline-7,12-dione,1,2,3,4-tetrahydro-8,11-dihydroxy-4-(2-hydroxyethyl)-6-[[2-[(2-hydroxyethyl)amino]ethyl]amino]-

Chemical structure of Naphtho[2,3-f]quinoxaline-7,12-dione,1,2,3,4-tetrahydro-8,11-dihydroxy-4-(2-hydroxyethyl)-6-[[2-[(2-hydroxyethyl)amino]ethyl]amino]-, CAS 137132-70-8
AG007ZTF
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 137132-70-8
Catalog Number AG007ZTF(AGN-PC-0PL9KD)
Chemical Name Naphtho[2,3-f]quinoxaline-7,12-dione,1,2,3,4-tetrahydro-8,11-dihydroxy-4-(2-hydroxyethyl)-6-[[2-[(2-hydroxyethyl)amino]ethyl]amino]-
IUPAC Name 8,11-dihydroxy-4-(2-hydroxyethyl)-6-[2-(2-hydroxyethylamino)ethylamino]-2,3-dihydro-1H-naphtho[3,2-f]quinoxaline-7,12-dione
InChI InChI=1S/C22H26N4O6/c27-9-6-23-3-4-24-12-11-13-20(25-5-7-26(13)8-10-28)19-16(12)21(31)17-14(29)1-2-15(30)18(17)22(19)32/h1-2,11,23-25,27-30H,3-10H2
InChI Key GJMHXLAWJIOZMT-UHFFFAOYSA-N
MDL Number MFCD09966043
Molecular Formula C22H26N4O6
Molecular Weight 442.4650
SMILES OCCNCCNc1cc2N(CCO)CCNc2c3C(=O)c4c(O)ccc(O)c4C(=O)c13
Synonyms
8,11-dihydroxy-4-(2-hydroxyethyl)-6-((2-((2-hydroxyethyl)amino)ethyl)amino)-1,2,3,4,7,12-hexahydronaphtho(2,3-f)quinoxaline-7,12-dione, DHHNQD, 137132-70-8, Mitoxantrone Impurity D, 8,11-dihydroxy-4-(2-hydroxyethyl)-6-(2-(2-hydroxyethylamino)ethylamino)-1,2,3,4-tetrahydronaphtho[2,3-f]quinoxaline-7,12-dione, Dhhnqd, Naphtho[2,3-f]quinoxaline-7,12-dione,1,2,3,4-tetrahydro-8,11-dihydroxy-4-(2-hydroxyethyl)-6-[[2-[(2-hydroxyethyl)amino]ethyl]amino]-, 8,11-Dihydroxy-4-(2-hydroxyethyl)-6-((2-((2-hydroxyethyl)amino)ethyl)amino)-1,2,3,4,7,12-hexahydronaphtho(2,3-f)quinoxaline-7,12-dione, AE-641/11403647, ACMC-20mwgh, (Mitoxantrone Impurity D)", AC1L309N, SCHEMBL3275895, CTK4C0665, DTXSID30160085, ZINC19802029, AKOS030241465, FT-0672424, Mitoxantrone (2-Hydroxyethyl)piperazine Impurity(Mitoxantrone Impurity D), 1,2,3,4-Tetrahydro-4-(2-hydroxyethyl)-6-[[2-[(2-hydroxyethyl)amino]ethyl]amino]-8,11-dihydroxynaphtho[2,3-f]quinoxaline-7,12-dione, 1,2,3,4-Tetrahydro-8,11-dihydroxy-4-(2-hydroxyethyl)-6-[[2-[(2-hydroxyethyl)amino]ethyl]amino]naphtho[2,3-f]quinoxaline-7,12-dione, 8,11-dihydroxy-4-(2-hydroxyethyl)-6-({2-[(2-hydroxyethyl)amino]ethyl}amino)-1,2,3,4-tetrahydronaphtho[2,3-f]quinoxaline-7,12-dione, 8,11-dihydroxy-4-(2-hydroxyethyl)-6-[[2-[(2-hydroxyethyl)-amino]-ethyl]-amino]-1,2,3,4,7,12-hexahydronaphtho-[2,3-f]-quinoxaline-7,12-dione, 8,11-dihydroxy-4-(2-hydroxyethyl)-6-[2-(2-hydroxyethylamino)ethylamino]-2,3-dihydro-1H-naphtho[3,2-f]quinoxaline-7,12-dione, Naphtho(2,3-f)quinoxaline-7,12-dione, 8,11-dihydroxy-1,2,3,4-tetrahydro-4-(2-hydroxyethyl)-6-((2-((2-hydroxyethyl)amino)ethyl)amino)-, CID132032, C22-H26-N4-O6, CS-T-58865, Mitoxantrone (2-Hydroxyethyl)piperazine Impurity, 8,11-dihydroxy-4- -6-((2-( -1,2,3,4,7,12-hexahydronaphtho quinoxaline-7,12-dione,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited